Physician profile
Mark L Blucher
NPI 1568433951
$3,399.70
in general payments reported to CMS, 2019-2025
31 companies · $1,362 in 2025
The $1,362 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $79.13 · 2021: $116 · 2022: $688 · 2023: $298 · 2024: $506 · 2025: $1,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,507 · Travel and Lodging: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,506.91 |
| Travel and Lodging | $658.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,406.28 | 2022-2025 | |
| Edwards Lifesciences Corporation | $378.35 | 2019-2025 | Mitris Resilia Mitral Valve, Carpentier-Edwards Physio Annuloplasty Ring With Holder - Mitral |
| Atricure, INC. | $317.98 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Ethicon US, LLC | $252.29 | 2022-2025 | Echelon; Endopath, Prolene, Stratafix |
| Corcym INC | $182.01 | 2022-2025 | Mi Detach - Aortic Cross Clamp - Delivery System Kit |
| Baxter Healthcare | $133.14 | 2019-2023 | Perclot, Preveleak, Tisseel |
| Tela Bio, INC. | $98.77 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Getinge USA Sales, LLC | $66.13 | 2019-2022 | |
| Angiodynamics, INC. | $62.07 | 2022-2023 | Alphavac |
| Abbott Laboratories | $48.81 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $38.19 | 2025 | |
| Zimmer Biomet Holdings, INC. | $37.57 | 2019 | |
| Solventum Corporation | $31.46 | 2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo |
| Pfizer INC. | $31.25 | 2019 | |
| Davol INC. | $30.00 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $27.18 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $26.74 | 2025 | Assure Wcd |
| Daiichi Sankyo INC. | $21.67 | 2024 | Enhertu |
| Elutia, INC. | $21.23 | 2021 | |
| Pinnacle Biologics, INC | $21.06 | 2024 | Photofrin |
| Lemaitre Vascular, INC. | $19.68 | 2023 | Restoreflow |
| Polynovo North America LLC | $19.28 | 2024 | Novosorb Btm |
| Portola Pharmaceuticals, LLC | $18.79 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.42 | 2023-2024 | Lifevest |
| Aesculap, INC. | $15.05 | 2019 | |
| Smith+Nephew, INC. | $14.89 | 2019 | |
| Stryker Corporation | $14.56 | 2025 | Stryker Varispeed, Na |
| Trevena, INC. | $14.01 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $12.73 | 2022 | |
| Lsi Solutions INC | $12.20 | 2020 | |
| Veran Medical Technologies, INC. | $8.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Blucher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.